This page does not provide medical advice, diagnosis, prescriptions, or instructions for using unapproved products.
Research-only listings in the UAE
These listings show availability, not medical approval or effectiveness. Nova products are sold for in-vitro laboratory research only.
An experimental growth-hormone releasing analogue
CJC-1295 has been studied for effects on growth-hormone signalling, but it is promoted online far beyond the limited clinical evidence. Claims about fat loss, muscle gain, sleep, or anti-ageing require direct, well-controlled human evidence and cannot be inferred from hormone changes alone.
Hormonal effects require medical context
Manipulating growth-hormone pathways can have metabolic and other systemic effects. Symptoms attributed to “low peptides” are non-specific and should not be diagnosed through a sales questionnaire.
An unapproved vial adds manufacturing, sterility, and labelling uncertainties to the biological risk.
Competitive sport
Growth-hormone releasing factors are relevant to anti-doping rules. Athletes should use current official resources rather than gym or clinic assurances.
Frequently asked questions
Is this page medical advice?
No. It is general educational information. A licensed UAE healthcare professional should assess individual symptoms, risks, medicines, and treatment decisions.
Does appearing online mean a peptide is approved in the UAE?
No. Online availability, social-media promotion, and international shipping do not establish UAE product registration or permission for human use.
Sources and further reading
This page was checked for evidence labels, regulatory wording, and unsupported health claims. Clinical expert review will be identified by name when available.